The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Determinants of permanent liver limited disease (pLLD) in metastatic colorectal cancer (mCRC).
 
Francesc Salva
Honoraria - Amgen; Merck Serono; Roche; Sanofi; SERVIER
Consulting or Advisory Role - Amgen
 
Cristina Dopazo
No Relationships to Disclose
 
René Adam
Honoraria - Merck; Sanofi
 
Hugo Pinto Marques
No Relationships to Disclose
 
Darius Mirza
Stock and Other Ownership Interests - OrganOx
 
Alessandro Ferrero
No Relationships to Disclose
 
Felice Giuliante
No Relationships to Disclose
 
Gernot Kaiser
No Relationships to Disclose
 
Real Lapointe
No Relationships to Disclose
 
Marek Krawczyk
No Relationships to Disclose
 
Christophe Laurent
No Relationships to Disclose
 
Maximiliano Gelli
No Relationships to Disclose
 
Jose Guilherme Tralhao
No Relationships to Disclose
 
Santiago Lopez Ben
No Relationships to Disclose
 
Irinel Popescu
No Relationships to Disclose
 
Helena Isoniemi
No Relationships to Disclose
 
Catherine Hubert
No Relationships to Disclose
 
Vladimir Evgenievich Zagainov
No Relationships to Disclose
 
Axel Andres
No Relationships to Disclose
 
Elena Elez
Honoraria - Amgen; Array BioPharma; Bristol-Myers Squibb; Merck; Merck Serono; Novartis; Roche; Sanofi/Aventis; Seagan; SERVIER
Consulting or Advisory Role - Amgen; Array BioPharma; Bayer; Bristol Myers Squibb; Merck Serono; MSD; Pierre Fabre; Roche; Sanofi; SERVIER
Research Funding - Amgen (Inst); Array BioPharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Debiopharm Group (Inst); Genentech (Inst); HalioDx (Inst); Hutchison MediPharma (Inst); Janssen-Cilag SA (Inst); MedImmune (Inst); Menarini (Inst); Merck (Inst); Merck Sharp&Dohme de España SA (Inst); Merus NV (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); Pierre Fabre (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Amgen; Array BioPharma; Bristol-Myers Squibb; Merck Serono; Roche; Sanofi; SERVIER